Past Events by Category
Why do most patients with epithelial cancers not respond to T cell checkpoint blockade? HHS Only
Monday, April 25, 2016
Douglas T. Fearon, M.D., Ph.D., Cold Spring Harbor Laboratory
Category: NCI CCR Eminent Lectures (HHS Only)
Dissecting KRAS-driven Pancreatic Tumorigenesis HHS Only
Monday, March 21, 2016
Brain Lewis, Ph.D., Associate Professor, Molecular, Cell and Cancer Biology, University of Massachusetts Medical School
Category: NCI CCR Eminent Lectures (HHS Only)
Protein Phosphorylation and Cell Signaling in Cancer HHS Only
Monday, February 22, 2016
Tony Hunter, Ph.D., American Cancer Society Professor, Renato Dulbecco Chair, Molecular and Cell Biology Laboratory Director, Salk Institute Cancer Center, The Salk Institute For Biological Sciences
Category: NCI CCR Eminent Lectures (HHS Only)
Mediator: A Multifunctional Regulator of RNA Polymerase II Transcription HHS Only
Monday, May 18, 2015
Joan Conaway, Ph.D., Helen Nelson Distinguished Chair, Stowers Institute for Medical Research, Professor, Department of Biochemistry & Molecular Biology, The University of Kansas School of Medicine
Category: NCI CCR Eminent Lectures (HHS Only)
Principles of Drug Resistance and Cancer Precision Medicine HHS Only
Monday, April 27, 2015
Levi A. Garraway, M.D., Ph.D., Assoc. Prof. of Medicine, Harvard Medical School Director, Joint Center for Cancer Precision Medicine Dept. of Med. Oncology, Dana Farber Cancer Institute Assoc. Physician, Brigham and Women's Hospital Senior Associate Member, Broad Institute
Category: NCI CCR Eminent Lectures (HHS Only)
Understanding and Overcoming Resistance to Cancer-Directed Immunity HHS Only
Monday, March 23, 2015
Louis M. Weiner, M.D., Director, Georgetown Lombardi Comprehensive Cancer Center Chair, Department of Oncology, Georgetown University Medical Center
Category: NCI CCR Eminent Lectures (HHS Only)